Taverlyn

GLP-1 & GIP analogs

Semaglutide

CAS
910463-68-2
MW
4113.6 g/mol
Half-life
~1 week

Semaglutide is studied as a GLP-1 receptor agonist for glucose-regulation and satiety-signalling research.

€140.00VAT incl.

Batch TVL-2608-11 · 99.4%

GDPR by default
ISO/GMP certified production
Batch-level COA on every order
EU warehouse, 2–5 days

Ships from our EU warehouse, 2–5 business days.

Research use only. Not for human or animal consumption. Age and research-use verification required at checkout.